Antioxidants (May 2022)

An In Vitro Study of Saffron Carotenoids: The Effect of Crocin Extracts and Dimethylcrocetin on Cancer Cell Lines

  • Kyriaki Hatziagapiou,
  • Olti Nikola,
  • Sofia Marka,
  • Eleni Koniari,
  • Eleni Kakouri,
  • Maria-Eleftheria Zografaki,
  • Sophie S. Mavrikou,
  • Charalabos Kanakis,
  • Emmanouil Flemetakis,
  • George P. Chrousos,
  • Spyridon Kintzios,
  • George I. Lambrou,
  • Christina Kanaka-Gantenbein,
  • Petros A. Tarantilis

DOI
https://doi.org/10.3390/antiox11061074
Journal volume & issue
Vol. 11, no. 6
p. 1074

Abstract

Read online

Crocus sativus L. has various pharmacological properties, known for over 3600 years. These properties are attributed mainly to biologically active substances, which belong to the terpenoid group and include crocins, picrocrocin and safranal. The aim of the current work was to examine the effects of crocins (CRCs) and their methyl ester derivate dimethylcrocetin (DMCRT) on glioblastoma and rhabdomyosarcoma cell lines, in terms of cytotoxicity and gene expression, implicated in proapoptotic and cell survival pathways. Cell cytotoxicity was assessed with Alamar Blue fluorescence assay after treatment with saffron carotenoids for 24, 48 and 72 h and concentrations ranging from 22.85 to 0.18 mg/mL for CRCs and 11.43 to 0.09 mg/mL for DMCRT. In addition, BAX, BID, BCL2, MYCN, SOD1, and GSTM1 gene expression was studied by qRT-PCR analysis. Both compounds demonstrated cytotoxic effects against glioblastoma and rhabdomyosarcoma cell lines, in a dose- and time-dependent manner. They induced apoptosis, via BAX and BID upregulation, MYCN and BCL-2, SOD1, GSTM1 downregulation. The current research denotes the possible anticancer properties of saffron carotenoids, which are considered safe phytochemicals, already tested in clinical trials for their health promoting properties.

Keywords